These immunomodulatory cytokines are also responsible for an increase in the T cell subsets, orchestrating phenotypic shifts in the CD4 T cell subtypes, and play a role in the increasing cytotoxic T cell activity in the tumor microenvironment of CD47 deficient tumors. The gene discussed is CD47; the disease is neoplasm.